SciELO - Scientific Electronic Library Online

 
vol.23 issue4Aortic valve replacement with different types of prosthesis: are there differences in the outcomes during hospital phase?Risk factors in septuagenarians or elderly patients undergone coronary artery bypass grafting and or valves operations author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Revista Brasileira de Cirurgia Cardiovascular

Print version ISSN 0102-7638

Abstract

SILVA, Kátia Regina da et al. Warfarin prevents venous obstruction after cardiac devices implantation in high-risk patients: partial analysis. Rev Bras Cir Cardiovasc [online]. 2008, vol.23, n.4, pp. 542-549. ISSN 0102-7638.  http://dx.doi.org/10.1590/S0102-76382008000400015.

OBJECTIVES: To evaluate the efficacy of prophylactic use of warfarin in patients with high risk of lead-associated thrombosis. METHODS: Clinical, prospective, randomized and blinded study, in patients submitted to first transvenous leads implantation with LVEF <0.40 and/or previous ipsilateral temporary pacing. After device implantation, patients were randomly assigned to placebo or warfarin. Periodical clinical and laboratorial evaluations were performed to anticoagulant management. After a six-month period, every patient was submitted to a digital subtraction venography. From February 2004 to November 2006, 101 patients underwent randomization. Baseline characteristics were similar in both groups (P=NS). RESULTS: Venographic analysis showed 31.4% of venous obstructions in patients assigned to warfarin as compared with 57.1% in patients assigned to placebo (RR= 0.57 [95% CI, 0.33 to 0.98]; P=0.015). In the warfarin group, 72% of the PT/INR tests were in therapeutic INR range. Only one patient required warfarin discontinuation and cross-over to placebo group due to gastrointestinal bleeding. CONCLUSIONS: These preliminary results showed that the anticoagulation therapy has been safe and reduced the frequency of venous thrombosis after transvenous cardiac devices implantation in high risk patients.

Keywords : Cardiac pacing, artificial; Postoperative complications; Venous thrombosis; Anticoagulants; Clinical trial.

        · abstract in Portuguese     · text in English | Portuguese     · pdf in English | Portuguese